Pattern of care and quality in the treatment of breast cancer. Evaluation of the data from Hesse 1996-2002;Versorgungsstruktur und qualität bei der behandlung des mammakarzinoms: Eine untersuchung am beispiel der daten aus Hessen 1996-2002

Geburtshilfe und Frauenheilkunde

Volumn 63, Issue 8, 2003, Pages 743-751

  Du Bois, Andreas ^a,b   Misselwitz, B ^b   Stillger, R ^b   Jackisch, C ^c   Schwab, R ^a   Gnauert, K ^a   Hils, R ^a   Wagner, U ^b,c  

^a Dr Horst Schmidt Kliniken Wiesbaden (HSK)   (Germany)

^b Qualitätssicherung Hessen ^*  (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Breast cancer; Outcome; Pattern of care; Quality assurance

Indexed keywords

STEROID RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; CANCER SURGERY; CAREGIVER; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORTALITY; PATIENT CARE; QUALITY CONTROL; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0141514618     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42147     Document Type: Article

References (33)

1. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland und Robert-Koch-Institut (2002). Krebs in Deutschland, Häufigkeiten und Trends. 3. erw. Ausg. Saarbrücken, 2002
2. GLOBOCAN (2000). Cancer incidence, mortality, and prevalence worldwide. CancerBase No. 5. Lyon: IARC, 2000
3. Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at age 20-69 years. Lancet 2000; 355: 1822
4. Levi F, Lucchini F, Negri E, La Vecchia C. The fall in breast cancer mortality in Europe. Eur J Cancer 2001; 37: 1409-1412
5. Berrino F, Sant M, Verdecchia A et al (eds). Survival of cancer patients in Europe. The EUROCARE study. Lyon: IARC Scientific Publications No. 132, 1995
6. Berrino F, Capocaccia R, Esteve J et al (eds), Survival of cancer patients in Europe: the EUROCARE-2 study. Lyon: IARC Scientific Publications No. 151, 1999
7. Ayanian JZ, Kholer BA, Abe T et al. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 1993; 329: 326-331
8. Sosa JA, Bowman HM, Gordon TA et al. Importance or hospital volume in the overall management of pancreatic cancer. Ann Surg 1998; 228: 429-438
9. Birkemeyer JD, Siewers AE, Finlayson EVA et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-1137
10. Schrag D, Cramer LD, Bach PB et al. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 2000; 284: 3028-3035
11. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280: 1747-1751
12. Bach PB, Cramer LD, Schrag D et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 2001; 345: 181-188
13. Eisenkop SM, Spirtos NM, Montag TW, Nalick RH, Wang HJ. The impact of subspeciality training on the management of advanced ovarian cancer. Gynecol Oncol 1992; 47: 203-209
14. Junor EJ, Hole DJ, McNulty I, Mason M, Young J. Specialist gynecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol 1999; 106: 1130-1136
15. Malin JL, Schuster MA, Kahn KA, Brook RH. Quality of breast cancer care: what do we know? J Clin Oncol 2002; 20: 4381-4393
16. McKee MD, Cropp MD, Hyland A et al. Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma. Cancer 2002; 95: 704-712
17. Kotwall CA, Covington DL, Rutledge R, Churchill MP, Meyer AA. Patient, hospital, and surgeon factors associated with breast conservation surgery. Ann Surg 1996; 224: 419-429
18. Curran D, van Dongen JP, Aaronson NK et al. Quality of life of early breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10,801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Cooperative Group (BCCG). Eur J Cancer 1998; 34: 307-314
19. Geraedts M, Neumann M. Mindestmenge als alleiniger Qualitä tsindikator unzureichend. Dtsch Ärztebl 2003; 100: A 381-382
20. Roohan PJ, Bickell NA, Baptiste MS et al. Hospital volume differences and five-year survival from breast cancer. Am J Public Health 1998; 88: 454-457
21. Sainsbury R, Howard B, Rider L, Johnston C, Round C. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995; 345: 1265-1270
22. Ma M, Bell J, Campbell S et al. Breast cancer management: is volume related to quality? Br J Cancer 1997; 75: 1652-1659
23. Gnauert K, Löhr A, Eitelbach F, du Bois A, Müller H. Minimal invasive Mammadiagnostik: eine Studie über stereotaktische Biopsie mit dem ABBI-System-ein wichtiger Eckpfeiler in der Mammadiagnostik? Geburtsh Frauenheilk 2001; 61: 85-91
24. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ 1996; 312: 145-148
25. du Bois A, Pfisterer J, Kellermann L, Kreienberg R. Die Therapie des fortgeschrittenen Ovarialkarzinoms in Deutschland: welchen Einfluss hat die Teilnahme an klinischen Studien? Geburtsh Frauenheilk 2001; 61: 863-871
26. Gnant M on Behalf of the Austrian Breast & Colorectal Cancer Study Group. Impact of participation in randomized clinical trials on survival of women with early stage breast cancer. Proc Am Soc Clin Oncol 2000; 19: 74a (abstr 287)
27. EUSOMA. The requirements of a specialist breast unit. Eur J Cancer 2000; 36: 2288-2293
28. Perry NM on behalf of the EUSOMA working party. Quality assurance in the diagnosis of breast disease. Eur J Cancer 2001; 37: 159-172
29. Rutgers EJTh for the EUSOMA consensus group. Quality control in the locoregional treatment of breast cancer. Eur J Cancer 2001; 37: 447-453
30. Schulz KD, Kreienberg R, Albert US, Fischer R. Konzertierte Aktion zur Brustkrebs-Früherkennung in Deutschland. Forum Dt Krebs Ges 2001; 6: 21-25
31. Alberts US, Schulz KD. Aktuelle Entwicklung der Brustkrebs-Frü herkennung in Deutschland und im internationalen Vergleich. Onkologe 2002; 8: 1040-1052
32. du Bois A. Erster Schritt zur Qualitätsverbesserung. Dtsch Arztebl 2003; 100: A 900 (letter)
33. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International consensus panel on the treatment of primary breast cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001; 19: 3817-3827